Functional and pathophysiological study of disease processes in humans and animal systems: Role of magnetic resonance imaging and in vivo MR spectroscopy

Current Science

Volumn 86, Issue 1, 2004, Pages 42-61

  Jagannathan, N R ^a  

^a ALL INDIA INSTITUTE OF MEDICAL SCIENCES   (India)

Author keywords

[No Author keywords available]

Indexed keywords

ANIMALIA;

EID: 4444289510     PISSN: 00113891     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (138)

1. Damadian, R., Tumor detection by nuclear magnetic resonance. Science, 1971, 171, 1151-1153.
2. Lauterbur, P. C., Image formation by induced local interaction: examples employing nuclear magnetic resonance. Nature, 1973, 242, 190-191.
3. Mansfield, P. and Maudsley, A. A., Planar and line-scan spin imaging by NMR. Proc. XIXth Congress Ampere, Heidelberg, 1976, pp. 247-252.
4. Andrew, E. R., Bottomley, P. A., Hinshaw, W. S., Holland, G. N., Moore, W. S. and Simoraj, C., NMR images by the multiple sensitive point method: application to larger biological systems. Phys. Med. Biol., 1977, 22, 971-974.
5. Stark, D. D. and Bradley W. G., Magnetic Resonance Imaging, Mosby, New York, 1998.
6. Argov, Z., Lofberg, M. and Arnold, D. L., Insights into muscle diseases gained by phosphorus magnetic resonance spectroscopy. Muscle Nerve, 2000, 23, 1316-1334.
7. Jagannathan, N. R., MR Imaging and Spectroscopy in Pharmaceutical and Clinical Research, Jaypee Brothers, New Delhi, 2001.
8. Gadian, D. G., NMR and its Application to Living Systems, Clarendon, Oxford, 1982.
9. Gunther, H., NMR Spectroscopy, Basic Principles, Concepts and Applications in Chemistry John Wiley, New York, 1982.
10. Mukherji, S. K., Clinical Applications of Magnetic Resonance Spectroscopy, John Wiley, New York, 1998.
11. Danielsen, E. R. and Ross, B. D., Magnetic Resonance Spectroscopy Diagnosis of Neurological Diseases, Marcel Dekker, New York, 1999.
12. Young, I. R. and Charles, H. C., MR Spectroscopy Clinical Applications and Techniques, Martin Dunitz, Cambridge, 1996.
13. Edelman, R. R., Hesselink, J. R. and Zlatkin, M. B., Clinical Magnetic Resonance Imaging, W B Saunders, Philadelphia, 1995, 2nd edn.
14. Arlert, I. P., Bougertz, G. N. and Manchal, G., Magnetic Resonance Angiography, Springer, Berlin, 1996.
15. Duerinckx, A. J., Coronary MR angiography. Radiol. Clin. N. Am., 1996, 37, 273-318.
16. Le Bihan, D., Diffusion and Perfusion Magnetic Resonance Imaging, Raven Press, New York, 1985.
17. Noris, D. G., Implications of bulk motion for diffusion-weighted imaging experiments: effects, mechanisms, and solutions. J. Magn. Reson. Imaging, 2001, 13, 486-495.
18. Le Bihan, D., Mangin, J. F., Poupon, C., Clark, C. A., Pappata, S., Molko, N. and Chabriat, H., Diffusion tensor imaging: concepts and applications. J. Magn. Reson. Imaging, 2002, 13, 534-546.
19. Ozscunar, Y. and Sorensen, A. G., Diffusion- and perfusion-weighted MRI in human acute ischaemic stroke: technical considerations. Top. Magn. Reson. Imaging, 2000, 11, 259-272.
20. Molko, N. and Chabriat, H., Diffusion tensor imaging: concepts and applications. J. Magn. Reson. Imaging, 2001, 13, 534-546.
21. Qui, H., Hedlund, L. W., Gewalt, S. L., Benveniste, H., Bare, T. M. and Johnson, G. A., Progression of a focal ischaemic lesion in rat brain during treatment with a novel glycine/NMDA antagonist: An in vivo 3D diffusion weighted MR microscopy study. J. Magn. Reason. Imaging, 1997, 7, 739-744.
22. Sinha, K., Degaonkar, M. N., Jagannathan, N. R. and Gupta, Y. K., Effect of melatonin on ischaemic reperfusion injury induced by middle cerebral artery occlusion in rats. Eur. J. Pharmacol., 2001, 428, 185-192.
23. Gupta, Y. K., Singh, K., Choudhary, G. and Jagannathan, N. R., Protective effect of adenosine against neuronal injury induced by middle cerebral artery occlusion as evident by diffusion weighted imaging. Pharm. Biochem. Behav., 2002, 72, 569-572.
24. Degaonkar, M. N., Khubchandani, M., Dhawan, J. D., Jayasundar, R. and Jagannathan, N. R., Sequential proton MRS study of brain metabolite changes monitored during a complete pathological cycle of demyelination and remyelination in a lysophosphatidyl choline (LPC)-induced experimental demyelinating lesion model. NMR Biomed., 2002, 15, 293-300.
25. Barbier, E. L., Lamalle, L. and Decorps, M., Methodology of brain perfusion imaging. J. Magn. Reson. Imaging, 2001, 13, 496-520.
26. Ogawa, S., Lee, T. M., Nayak, A. S. and Glynn, P., Oxygenation-sensitive contrast in magnetic resonance imaging of rodent brain at high fields. Magn. Reson. Med., 1990, 4, 68-78.
27. Ogawa, S., Lee, T. M., Kay, A. R. and Tank, D. W., Brain magnetic resonance imaging with contrast dependent on blood oxygenation. Proc. Natl. Acad. Sci. USA, 1990, 87, 9868-9872.
28. Kim, S. G. and Ugurbil, K., Functional magnetic resonance imaging of the human brain. J. Neurosci. Methods, 1997, 74, 229-243.
29. Kwong, K. K. et al., Dynamic magnetic resonance imaging of human brain activity during primary sensory stimulation. Proc. Natl. Acad. Sci. USA, 1992, 89, 5951-5955.
30. Detre, J. A. and Floyd, T. F., Functional MRI and its applications to the clinical neurosciences. Neuroscientist, 2001, 7, 64-79.
31. Raichle, M. E., Functional brain imaging and human brain function. J. Neurosci., 2003, 23, 3959-3962.
32. Turner, R., Le Bihan, D., Moonen, C. T., Despres, D. and Frank, J., Echo planar time course MRI of cat brain oxygenation changes. Magn. Reson. Med., 1991, 22, 159-166.
33. Belliveau, J. W. et al., Functional mapping of the human visual cortex by magnetic resonance imaging. Science, 1991, 254, 716-719.
34. Kwong, K. K. et al., Dynamic magnetic resonance imaging of human brain activity during primary sensory stimulation. Proc. Natl. Acad. Sci. USA, 1992, 89, 5675-5679.
35. Bandettini, P. A., Wong, E. C., Hinks, R. S., Tikofsky, R. S. and Hyde, J. S., Time course EPI of human brain function during task activation. Magn. Reson. Med., 1992, 25, 390-397.
36. Ogawa, S. et al., Intrinsic signal changes accompanying sensory stimulation: Functional brain mapping with magnetic resonance imaging. Proc. Natl. Acad. Sci. USA, 1992, 89, 5951-5955.
37. Fox, P. T. and Raichle, M. E., Focal physiological uncoupling of cerebral blood flow and oxidative metabolism during somatosensory stimulation in human subjects. Proc. Natl. Acad. Sci. USA, 1986, 83, 1140-1144.
38. Kim, S. G., Ashe, J., Hendrich, K., Ellermann, J. M., Merkle, H., Ugurbil, K. and Georgopoulos, A. P., Functional magnetic resonance imaging of motor cortex: hemispheric asymmetry and handedness. Science, 1993, 261, 615-617.
39. Ruggieri, P. M. and Najm, I. M., MR imaging in epilepsy. Neurol. Clin., 2001, 19, 477-489.
40. Mattay, V. S. and Weinberger, D. R., Organization of the human motor system as studied by functional magnetic resonance imaging. Eur. J. Radiol., 1999, 30, 105-114.
41. Hinke, R. M. et al., Functional magnetic resonance imaging of Broca's area during internal speech. Neuroreport, 1993, 4, 675-678.
42. Benson, R. R. et al., Language dominance determined by whole brain functional MRI in patients with brain lesions. Neurology, 1999, 52, 798-809.
43. Binder, J. R. et al., Determination of language dominance using functional MRI: a comparison with the Wada test. Neurology, 1996, 46, 978-984.
44. Small, S. L. and Burton, M. W., Functional magnetic resonance imaging studies of language. Curr. Neurol. Neurosci. Rep., 2002, 2, 1-16.
45. Halpern, D. F., Sex Differences in Cognitive Abilities, Erlbaum, Hillsdale, 1992, 2nd edn.
46. Shaywitz, B. A. et al., Sex differences in the functional organization of the brain for language. Nature, 1995, 373, 607-609.
47. Frahm, J., Bruhn, H., Merboldt, K. D. and Hanicke, W., Dynamic MR imaging of human brain oxygenation during rest and photic stimulation. J. Magn. Reson. Imaging, 1992, 2, 501-505.
48. Tootell, R. B. H. et al., Functional analysis of V3A and related areas in human visual cortex. J. Neurosci., 1997, 17, 7060-7078.
49. Le Bihan, D. (ed.), Diffusion and Perfusion Magnetic Resonance Imaging: Applications to Functional MRI. Raven, New York, 1995.
50. Beach, F. A. and Holz-Tucker, A. M., Effects of different concentrations of androgen upon sexual behaviour in castrated male rats. J. Comp. Physiol., 1949, 42, 433-453.
51. Tandon, S., An fMRI study to localize the brain areas involved in post-ejaculatory refractory period in human subjects. M.Sc. thesis, All India Institute of Medical Sciences, New Delhi, 2003.
52. Jackson, G. D., New techniques in magnetic resonance and epilepsy. Epilepsia, 1994, 35, S2-S13.
53. Sheth, R. D., Epilepsy surgery: Presurgical evaluation. Neurol. Clin., 2002, 20, 1195-1215.
54. Detre, J. A., Sirven, J. I., Alsop, D. C., O'Connor, M. J. and French, J. A., Localization of sub-clinical activity by functional magnetic resonance imaging: correlation with invasive monitoring. Ann. Neurol., 1995, 38, 618-624.
55. Weiss, A. P. and Heckers, S., Neuroimaging of hallucinations: a review of the literature. Psychiatry Res., 1999, 20, 61-74.
56. Meisenzahl, E. M. and Schlosser, R., Functional magnetic resonance imaging research in psychiatry. Neuroimaging Clin. N. Am., 2001, 11, 365-374.
57. Callicott, J. H., An expanded role for functional neuroimaging in schizophrenia. Curr. Opin. Neurobiol., 2003, 13, 256-260.
58. 23Na MRI after transient focal cerebral ischaemia. Stroke, 2001, 32, 925-932.
59. Sandstede, J. J. et al., Assessment of myocardial infarction in humans with Na-23 MR imaging; comparison with cine MR imaging and delayed contrast enhancement. Radiology, 2001, 221, 222-228.
60. 23Na MRI accurately measures fixed charge density in articular cartilage. Magn. Reson. Med., 2002, 47, 284-291.
61. 19F magnetic resonance imaging of perfluorocarbons. Curr. Sci., 1999, 76, 753-762.
62. 129Xe. Nature, 1994, 370, 199-201.
63. Ebert, N. et al., Nuclear magnetic resonance image with hyper polarized helium. Lancet, 1996, 147, 1297-1299.
64. 129Xe. Nature, 370, 199-201.
65. Kauczor, H. U., Surkau, R. and Roberts, T., MRI using hyperpolarized noble gases. Eur. J. Radiol., 1998, 8, 820-827.
66. McAdams, H. P., Hatabu, H., Donnelly, L. F., Chen O Tadamura, E. and MacFall, J. R., Novel techniques for MR imaging of pulmonary air spaces. Magn. Reson. Imaging Clin. N. Am., 2000, 8, 205-219.
67. Salerno, M., Altes, T. A., Mugler, J. P., Nakatsu, M., Hatubu, H. and De Lange, E. E., Hyperpolarized noble gas MR imaging of the lung: potential clinical applications. Eur. J. Radiol., 2001, 40, 33-44.
68. Buonano, F. S. et al., Proton NMR imaging in experimental ischaemic infarction. Stroke, 1983, 14, 173-177.
69. Sauter, P., Rudin, M. and Wiederhold, K. H., Reduction of neural damage in irreversible cerebral ischaemia by calcium antagonists. Neurochem. Pathol., 1988, 9, 211-236.
70. Sauer, D., Allegrini, P. R. and Fagg. G. E., The competitive NMDA antagonist CGP 40116 is a potent neuroprotectant in a rat model of focal cerebral ischaemia. J. Neural. Trans. Suppl., 1994, 43, 81-89.
71. Sauter, A. and Rudin, M., Calcium antagonists for reduction of brain damage in stroke. J. Cardiovasc. Pharmac. (Suppl. 1), 1990, 15, 543-547.
72. Muruganandham, M., Kasiviswanathan, A., Jagannathan, N. R., Raghunathan, P., Jain, P. C. and Jain, V., Diltiazem enhances tumour blood flow: MRI study in a murine tumour. Int. J. Radiat. Oncol. Biol. Phys., 1999, 43, 413-421.
73. Koretsky, A. P., Brosnan, M. J., Chen, J. Chen, J. and Van Dyke, T., NMR determination of creatine kinase expressed in liver of transgenic mice: Determination of free ADP levels. Proc. Natl. Acad. Sci. USA, 1990, 87, 3112-3116.
74. Roman, B. B., Foley, J. M., Meyer, R. A. and Koretsky, A. P., Contractile and metabolic effects of increased creatine kinase activity in mouse skeletal muscle. Am. J. Pathol., 1996, 270, C1236-1245.
75. Jolesz, F. A. and Young, I. R. (eds), Interventional MR: Techniques and Clinical Experience, London, Martin Dunitz, 1998.
76. Hore, P. J., Solvent suppression in Fourier transform nuclear magnetic resonance. J. Magn. Reson., 1983, 55, 283-300.
77. Dumoulin, C. L., A method of chemical-shift selective imaging. Magn. Reson. Med., 1985, 2, 583-585.
78. 1H NMR chemical shift selective (CHESS) imaging. Phys. Med. Biol., 1985, 30, 341-344.
79. Frahm, J., Merboldt, K. D. and Hanicke, W., Localized proton spectroscopy using stimulated echoes. J. Magn. Reson., 1987, 72, 502-508.
80. Frahm, J., Bruhn, H., Gyngell, M. L., Merboldt, K. D., Hanicke, W. and Sauter, R., Localized high-resolution proton NMR spectroscopy using stimulated echoes: initial application to human brain in vivo. Magn. Reson. Med., 1989, 9, 79-93.
81. Bottomley, P. A., Selective volume method for performing localized NMR spectroscopy. U S Patent, 1984, 4, 480, 228.
82. Ordidge, R. J., Bendall, M. R., Gordon, R. E. and Connelly, A., Volume selection for in vivo biological spectroscopy. In Magnetic Resonance in Biology and Medicine (eds Govil, G., Khetrapal, C. L. and Saran, A., Tata McGraw Hill, New Delhi, 1985, pp. 387-397.
83. Brown, T. R., Kincaid, B. M. and Ugurbil, K., NMR chemical shift imaging in three dimensions. Proc. Natl. Acad. Sci. USA, 1982, 79, 3523-3526.
84. Maudsley, A. A., Hilal, S. K., Perman, W. H. and Simon, H. E., Spatially resolved high resolution spectroscopy by 'four dimensional' NMR. J. Magn. Reson., 1983, 51, 147-152.
85. 31P NMR. Magn. Reson. Med., 1988, 7, 319-336.
86. 31P MRS in humans by spectroscopic imaging. Magn. Reson. Med., 1989, 12, 291-305.
87. 1H NMR spectroscopic imaging. Magn. Reson. Med., 1990, 13, 62-76.
88. 1H MR spectroscopic imaging and PET. Radiology, 1990, 176, 791-799.
89. 31P MR spectroscopy in the evaluation of brain tumour treatment. Radiology, 1987, 165, 215-219.
90. 31P NMR spectroscopic investigation of human neuroblastoma in situ. N. Engl. J. Med., 1985, 312, 1500-1505.
91. Hope, P. L. et al., Cerebral energy metabolism studied with phosphorus NMR spectroscopy in normal and birth-asphyxiated infants. Lancet, 1984, 2, 366-370.
92. Younkin, D. P., Delivoria-Papadopoulos, M., Leonard, J. C., Subramanian, V. H., Eleff, S., Leigh, Jr. J. S. and Chance, B., Unique aspects of human newborn cerebral metabolism evaluated with phosphorus nuclear magnetic resonance spectroscopy. Ann. Neurol., 1984, 16, 581-586.
93. 31P MR spectra of the developing human brain during postnatal life. Work in progress. Radiology, 1989, 172, 197-199.
94. Podo, F., Tumor phospholipid metabolism. NMR Biomed., 1999, 12, 413-439.
95. Argov, Z., Lofberg, M. and Arnold, D. L., Insights into muscle diseases gained by phosphorus magnetic resonance spectroscopy. Muscle Nerve, 2000, 23, 1316-1334.
96. Kutsuzawa, T., Shioya, S., Kurita, D., Haida, M. and Yamabayashi, H., Effects of age on muscle energy metabolism and oxygnation in the forearm muscle. Med. Sci. Sports Exer., 2001, 33, 901-906.
97. 31P magnetic resonance spectroscopy) in chronic malnutrition. Acta. Pediaet., 1994, 83, 327-331.
98. 31P-nuclear magnetic studies of bioenergetic changes in skeletal muscle in malnourished human adults. Am. J. Clin. Nutr., 1998, 67, 39-43.
99. Taylor, D. J., Clinical utility of muscle MR spectroscopy. Semin. Musculoskel. Radiol., 2000, 4, 481-502.
100. 31P magnetic resonance spectroscopy of (human) skeletal muscle. Proc. Nutr. Soc., 1999, 58, 861-870.
101. 31P NMR spectroscopy of skeletal muscle in Becker dystrophy and DMD/BMD carriers. Altered rate of phosphate transport. J. Neurol. Sci., 1992, 109, 188-195.
102. 31P-MR spectroscopy study. Muscle Nerve, 1992, 15, 344-348.
103. Kemp, G. J., Taylor, D. J., Dunn, J. F., Frostick, S. P. and Radda, G. K., Cellular energetics of dystrophic muscle. J. Neurol. Sci., 1993, 116, 201-206.
104. Ronen, S. M. and Leach, M. O., Imaging biochemistry: applications to breast cancer. Breast Cancer Res., 2001, 3, 36-40.
105. 31P measurements of response to treatment. NMR Biomed., 1998, 11, 314-340.
106. Miller, B. L., A review of chemical issues in 1H NMR spectroscopy: N-acetyl-aspartate, creatine and choline. NMR Biomed., 1991, 4, 47-52.
107. Fleming, M. C. and Lowry, O. H., The measurement of free and N-acetylated aspartic acid in the nervous system. J. Neurochem., 1996, 13, 779-783.
108. Ross, B. D. and Michaelis, T., Clinical applications of magnetic resonance spectroscopy. Mag. Res. Q., 1994, 10, 191-247.
109. 1H spectroscopy. Glutamate, glutamine, myo-inositol and related metabolites. NMR Biomed., 1991, 4, 59-63.
110. Miller, B. L., Moats, R. A., Shonk, T., Ernst, T., Wolley, S. and Ross, B. D. Alzheimer diseases: Depiction of increased cerebral myo-inositol with proton MR spectroscopy. Radiology, 1993, 187, 433-437.
111. Castillo, M., Kwock, L. and Mukherji, S. K., Clinical applications of proton MR spectroscopy. AJNR Am. J. Neuroradiol., 1996, 17, 1-15.
112. Burtscher, I. M. and Holtas, S., Proton magnetic resonance spectroscopy in brain tumours: clinical applications. Neuroradiology, 2001, 43, 345-352.
113. 1H-MRS) in the diagnosis and management of patients with brain tumours. Curr. Opin. Oncol., 2002, 14, 292-298.
114. Ishimaru, H., Morikawa, M., Iwanaga, S., Kaminogo, M., Ochi, M. and Hayashi, K., Differentiation between high-grade glioma and metastatic brain tumour using single voxel proton MR spectroscopy. Eur. J. Radiol., 2001, 11, 1784-1791.
115. Herminghaus, S., Pilatus, U., Moller-Hartmann, W., Raab, P., Lanfermann, H., Scholte, W. and Zanella, F. E., Increased choline levels coincide with enhanced proliferative activity of neuroepithelial brain tumours. NMR Biomed., 2002, 15, 385-392.
116. 1H MR spectroscopy in patients with metastatic brain tumours: a multicenter study. Magn. Reson. Med., 1995, 33, 818-826.
117. 1H-MRS in vivo predicts the early treatment outcome of postoperative radiotherapy for malignant gliomas. Int. J. Radiat. Oncol. Biol. Phys., 2002, 52, 1271-1276.
118. Graham, G. D., Hwang, J. H., Rothman, D. L. and Prichard, J. W., Spectroscopic assessment of alterations in macromolecule and small molecule metabolite in human brain after stroke. Stroke, 2001, 32, 2797-2802.
119. Gupta, R. K. et al., Relationships between choline magnetic resonance spectroscopy, apparent diffusion coefficient and quantitative histopathology in human glioma. J. Neurooncol., 2000, 50, 215-226.
120. Jayasundar, R., Singh, V. P., Jain, V., Raghunathan, P. and Banerji, A. K., Inflammatory granulomas: evaluation with proton MRS. NMR Biomed., 1999, 12, 139-144.
121. Jagannathan, N. R., Desai, N. G. and Raghunathan, P., Brain metabolite changes in alcoholism: an in vivo proton magnetic resonance spectroscopy (MRS) study. Magn. Reson. Imaging, 1996, 14, 553-557.
122. Jagannathan, N. R., Tandon, N., Raghunathan, P. and Kochupillai, N., Reversal of abnormalities of myelination by thyroxin therapy in congenital hypothyroidism: localized in vivo proton magnetic resonance spectroscopy (MRS) study. Dev. Brain Res., 1998, 109, 179-186.
123. Stanley, J. A., In vivo magnetic resonance spectroscopy and its application to neuropsychiatrie disorders. Can. J. Psychiatry, 2002, 47, 315-326.
124. Kasai, K., Iwanami, A., Yamasue, H., Kuroki, N., Nakagome, K. and Fukuda, M., Neuroanatomy and neurophysiology in schizophrenia. Neurosci. Res., 2002, 43, 93-110.
125. 1H-MRS and tissue segmentation. Schizophr. Res., 2001, 52, 87-99.
126. 1H-magnetic resonance spectroscopy. Ann. N. Y. Acad. Sci., 2000, 904, 25-31.
127. Schick, F., Eismann, B., Jung, W. I., Hungers, H., Bunse, M. and Lutz, O., Comparison of localized proton NMR signals of skeletal muscle and fat tissue in vivo: two lipid compartments in muscle tissue. Magn. Reson. Med., 1993, 29, 158-167.
128. Jagannathan, N. R. and Wadhwa, S., In vivo proton magnetic resonance spectroscopy (MRS) study of post polio residual paralysis (PPRP) patients. Magn. Reson. Imaging, 2002, 20, 113-117.
129. Jagannathan, N. R., Singh, M., Govindaraju, V., Raghunathan, P., Coshic, O., Julka, P. K. and Rath, G. K., Volume localized in vivo proton MR spectroscopy of breast carcinoma: variation of water-fat ratio in patients receiving chemotherapy. NMR Biomed., 1998, 11, 414-422.
130. Jagannathan, N. R., Kumar, M., Raghunathan, P., Coshic, O., Julka, P. K. and Rath, G. K., Assessment of the therapeutic response of human breast carcinoma using in vivo volume localized proton magnetic resonance spectroscopy. Curr. Sci., 1999, 76, 777-782.
131. Jagannathan, N. R., Seenu, V., Coshic, O., Dwivedi, S. N., Julka, P. K., Srivastava, A. and Rath, G. K., Evaluation of total choline from in vivo volume localized proton MR spectroscopy and its response to neoadjuvant chemotherapy in locally advanced breast cancer. Br. J. Cancer, 2001, 84, 1016-1022.
132. 19F spin relaxation and localized spectroscopy of fluoxetine in human brain. Magn. Reson. Med., 1994, 31, 204-211.
133. 19F NMR. Br. J. Cancer, 1985, 50, 113-117.
134. 19F NMR study. Curr. Sci., 1999, 76, 677-680.
135. Wolf, W., Albright, M. J., Silver M. S., Weber, H., Reichardt, V. and Sauer, R., Fluorine-19 NMR spectroscopic studies of the metabolism of 5-flurouracil in the liver of patients undergoing chemotherapy. Magn. Reson. Imaging, 1987, 5, 165-169.
136. Renshaw, P. F. et al., Accumulation of fluoxetine and norfluoxetine in human brain during therapeutic administration. Am. J. Psychiatry, 1992, 149, 1592-1594.
137. Gonzalez, R. G., Guimaraes, A. R., Sachs, G. S., Rosenbaum, J. F., Garwood, M. and Renshaw, P. F., Measurement of human brain lithium in vivo by MR spectroscopy. Am. J. Neuroradiol., 1993, 14, 1027-1037.
138. Komoroski, R. A., Newton, J. E. O., Walker, E., Cardwell, D., Jagannathan, N. R., Ramaprasad, S. and Sprigg, J., In vivo NMR spectroscopy of lithium-7 in humans. Magn. Reson. Med., 1990, 15, 347-356.